Cavendish

Cavendish is pleased to have acted for Plant Health Care, Inc. in its acquisition by PI Industries Ltd for £32.8 million. Plant Health Care, a leading provider of innovative biological products, has been at the forefront of developing sustainable solutions for agriculture. This acquisition will significantly enhance PI Industries' portfolio, whilst enabling an expedited commercial scale-up of Plant Health Care’s products by leveraging PI’s complementary technologies, expertise and infrastructure. Peter Lynch, CA, Associate Director at Cavendish, remarked: "This transaction is a testament to the increasing value placed on sustainable agricultural solutions. The integration of Plant Health Care’s cutting-edge technologies with PI Industries’ global reach will create a formidable force in the market, driving innovation and sustainability in agriculture. We are delighted to have been part of this significant step towards a more sustainable future for the industry." Read more here - https://lnkd.in/e4maaEAs #naturalresources #publicmanda #sustainableagriculture

Cavendish is pleased to announce the successful sale of NFS Technology Group to Korbyt, in partnership with Clearhaven Partners. This strategic transaction marks a significant milestone in the evolving workplace technology sector.   NFS Technology, a global leader in meeting room management and resource scheduling, has been at the forefront of enhancing operational efficiency for businesses worldwide. Their integration with Korbyt’s workplace experience platform will create a comprehensive suite of tools aimed at boosting productivity and employee engagement.   Anthony Platt, Head of Technology at Cavendish, commented: “We are delighted to have advised NFS Technology on this significant sale. This transaction highlights our deep expertise in the technology sector and marks our 13th successful deal this year. It’s a testament to the strength and dedication of the Cavendish Technology team to deliver exceptional outcomes for our clients in this fast-evolving sector.” Read more here - Cavendish deal team: John Farrugia, Paris McNicol-Outch, Tom Holland-Hibbert #technology #employeeengagement #software

At Cavendish, we delighted to have collaborated with leading Healthcare and Life Sciences analysts across the City to address critical challenges and opportunities for our sector. Together, we have penned a joint letter to the UK Government, highlighting six key themes to help the UK solidify its position as a global life sciences leader. Our proposals focus on improving capital flows, embracing NHS innovation, enhancing R&D tax relief, retaining top talent, driving entrepreneurialism, and pushing for bold, swift action. We believe these steps are essential for fostering a vibrant ecosystem that not only advances healthcare but also contributes significantly to the UK’s economic growth. This is about more than just policy—it’s about harnessing the full potential of the UK’s life sciences and healthcare sectors to benefit patients, businesses, and the economy. We look forward to engaging with government leaders to turn these proposals into action and drive forward a decade of growth. Many thanks to Matthew Neal for co-ordinating. #lifesciences #healthcare

This edition of the Cavendish Quarterly Consumer Note looks at the sector for Q2 2024 with the focus for this quarter on the travel sector. In it we explore the M&A activity in travel, driven by renewed consumer spend in the vertical, some positive economic trends and the desires of both buyers and sellers.   To download the report, please click here, or visit our website. https://lnkd.in/dn2Yiwub #consumer #travel #TravelSector #TravelIndustry #TravelTrends

Cavendish is pleased to announce that it has advised on the sale of DOFF PORTLAND GARDEN PRODUCTS to global pest control group Pelsis Group.   This is another successful deal for the Cavendish team in the horticultural and wider FMCG sectors.   Commenting on the news, Jonathan Buxton, Partner at Cavendish said: “Congratulations to the Doff shareholders and management team on this landmark transaction. Doff is a near-perfect fit with Pelsis, giving them a major consumer brand and a leading position in the environmentally-responsible gardening category.”     To read more about this, visit: https://lnkd.in/eakYyy2J

Cavendish is delighted to have advised Creative ITC on the minority investment from LDC, part of Lloyds Banking Group.   This is the 12th technology sector deal that the team have worked on this year, showcasing our expertise in advising ambitious UK companies in the space.   Commenting on the deal, Paris McNicol-Outch, Associated Director at Cavendish said: “We’re looking forward to supporting Creative ITC throughout its continued growth journey, which looks promising with the potential for acquisitions and further transactions in the future.”   Congratulations to all of the teams involved!   To read more about this, visit: https://lnkd.in/eY746hCs   #CloudService #Growth #Investment #PrivateEquity #Technology #Investors

To read our Annual Report, please see here https://lnkd.in/e3-YARMM.

To read our Annual Report, please see here https://lnkd.in/e3-YARMM.

Congratulations to our 18 runners who participated in the Standard Chartered Great City Race yesterday. The 5k course started at the Honourable Artillery Grounds making its way round famous landmarks, such as the Bank of England and St Paul’s Cathedral. Your perseverance and spirit made the evening truly enjoyable. Well done! Julian Blunt Kimberley Carstens Geoff Nash Trisyia Jamaludin Seamus Fricker Callum Davidson Daniel Hall Oscar Valeur-Adu Edward M. Francesca M. Michael Clifton Daniel Dwyer Leo Holdsworth Amy Mayer Richard Beckett Harry Radburn Ellen Hudson Elliott Jeans #GreatCityRace

Cavendish is delighted to have advised Intelligent Ultrasound Group PLC on the sale of its Clinical AI business to GE HealthCare for £40.5 million. This cross-border transaction underscores our expertise in the healthcare technology sector and supports GE HealthCare’s precision care strategy. This deal exemplifies our commitment to supporting innovative companies in achieving their strategic goals across an extensive sector portfolio. Read further details here - https://lnkd.in/eSNRXpjA Completion of the transaction remains subject to Intelligent Ultrasound Group plc shareholder approval and CMA and NS&I approvals.   Michael Jewell Giles Balleny Harry Radburn Ellen Hudson #lifesciences #healthcare #mergersandacquisitions